Abstract | BACKGROUND: METHODS: RESULTS: The mean interval of mechanical support between the two groups was comparable (group A vs B: 148 +/- 127 vs 104 +/- 61 days, n.s.). Accordingly, the cumulative support was much lower in group A (1051 days) as compared to group B (2091 days). In group B, 10 patients (50%) developed clinically evident thromboembolism. The number of events ranged from 1 to 10 (mean 1.4 +/- 2.3), with a total of 32. With addition of platelet inhibitors, the incidence of cerebral embolism dramatically dropped, as only one patient presented with transient ischemic attacks in group A (p < 0.05). Thoracic bleeding as defined by excessive drainage losses requiring redo thoracotomy did not increase (group A vs B: 22% vs 20%, n.s.). CONCLUSION:
|
Authors | C Schmid, M Weyand, D Hammel, M C Deng, D Nabavi, H H Scheld |
Journal | The Thoracic and cardiovascular surgeon
(Thorac Cardiovasc Surg)
Vol. 46
Issue 5
Pg. 260-2
(Oct 1998)
ISSN: 0171-6425 [Print] Germany |
PMID | 9885115
(Publication Type: Journal Article)
|
Chemical References |
- Anticoagulants
- Platelet Aggregation Inhibitors
- Dipyridamole
- Heparin
- Phenprocoumon
- Aspirin
|
Topics |
- Anticoagulants
(therapeutic use)
- Aspirin
(therapeutic use)
- Case-Control Studies
- Dipyridamole
(therapeutic use)
- Female
- Heart-Assist Devices
- Heparin
(therapeutic use)
- Humans
- Male
- Middle Aged
- Phenprocoumon
(therapeutic use)
- Platelet Aggregation Inhibitors
(therapeutic use)
- Thromboembolism
(etiology, prevention & control)
|